Epibiologics Appoints Ann Lee-Karlon As Chief Executive Officer And President, Extends Series A Financing To Over $70 Million
Round Type
Series A
Investors
Description
EpiBiologics, a biotechnology company advancing a next-generation antibody-based protein degradation platform and pipeline for membrane and extracellular drug targets, announced today that Ann Lee-Karlon, Ph.D., will join as Chief Executive Officer, President, and member of the Board of Directors. Dr. Lee-Karlon will focus on expanding EpiBiologics’ proprietary EpiTAC platform, establishing value-driven collaborations, and building the company’s pipeline of bispecific antibody protein degrader therapeutics.
Quick answer
EpiBiologics raised an undisclosed amount in a Series A round, dated July 20, 2023. Investors: GV, Vivo Capital, Polaris Partners, Mubadala Capital, Codon Capital, Taiho Ventures and Digitalis Ventures. EpiBiologics is based in San Mateo, California, United States.
- How much did EpiBiologics raise?
- EpiBiologics raised an undisclosed amount in a Series A round on July 20, 2023.
- Who invested in EpiBiologics?
- GV, Vivo Capital, Polaris Partners, Mubadala Capital, Codon Capital, Taiho Ventures and Digitalis Ventures are named as investors in this round.
- What does EpiBiologics do?
- EpiBiologics is advancing bispecific antibodies that selectively degrade membrane and soluble proteins, including GPCRs.
- Where is EpiBiologics based and how big is it?
- EpiBiologics is based in San Mateo, California, United States. Fundz records about 43 employees.
- Who are the decision-makers at EpiBiologics?
- Fundz holds 2 contacts at EpiBiologics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as EpiBiologics that raised within 45 days of this round, from Fundz verified event records.
- Delcath Systems raised $35M (Funding Round) on September 1, 2023.
- Cardio Flow, Inc. raised $100K (Seed) on September 1, 2023.
- Innovac Therapeutics raised $18M (Funding Round) on September 1, 2023.
- Measurlabs raised $2.7M (Seed) on September 1, 2023.
- Just Egg raised an undisclosed amount (Funding Round) on September 1, 2023.
- March Biosciences raised $9K (Pre-Seed) on September 1, 2023.
Who to call at EpiBiologics, and when
A new round usually means EpiBiologics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day EpiBiologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at EpiBiologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at EpiBiologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment EpiBiologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEpiBiologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.